Thu, 21st Jun 2018 10:25
LONDON (Alliance News) - Anti-microbial resistance-focused biotechnology developer Destiny Pharma PLC said Thursday it has appointed Nick Rodgers as an independent non-executive director with immediate effect.
Rodgers is currently chairman of South East Health Technologies Alliance, a non-profit UK health technology networking organisation.
Destiny Pharma shares were untraded at 109.90 pence each.
Destiny Pharma PLC - biotechnology company, focused on developing and commercialising medicines for life-threatening infections - Announces new data o...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Destiny Pharma. (DEST)